In the middle and late stages of cervical cancer, after active treatment, the survival rate of 5 years is not high, but there will be individual differences. Cervical cancer is a malignant tumor that originates from the cervix of the uterus, usually due to the persistent infection of high-risk HPV, and it is also a relatively common gynecological tumor in the female reproductive tract, with a better prognosis in early treatment. Cervical cancer patients may have no symptoms in the early stage and will only be detected through screening. With the development of the disease, vaginal bleeding, vaginal discharge, and other symptoms of tissue and organ invasion may also occur, which will seriously jeopardize the health of patients. Especially for middle and late stage cervical cancer patients, the overall prognosis is not very good, and the survival rate is not very high even if they cooperate with doctors for active treatment in time. It is recommended that women should cooperate with doctors to carry out standardized treatment as soon as possible after discovering cervical cancer, and choose appropriate treatment plan to improve the prognosis of patients.